Added to YB: 2024-07-25
Pitch date: 2024-07-23
TMDX [bullish]
TransMedics Group, Inc.
-17.42%
current return
Author Info
MMMT Wealth is a CPA who shares stock pitches in their newsletter. Sign up for the newsletter.
Company Info
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally.
Market Cap
$4.5B
Pitch Price
$153.53
Price Target
N/A
Dividend
N/A
EV/EBITDA
35.52
P/E
51.63
EV/Sales
7.99
Sector
Health Care Equipment and Supplies
Category
growth
3 Stocks That Will Beat The S&P 500 Over The Next Decade - TransMedics Group, Inc.
TMDX: OCS tech revolutionizing organ transplants. Q1 rev $96.9M (+133% YoY, +19% QoQ). FY24 guidance $400M (+66% YoY). 14 aviation planes, aiming for 20 EOY. Int'l expansion plans. R&D up 94%. High valuation justified by triple-digit growth & margin expansion. Potential for further beats/raises over 2yrs suggests significant upside remains.
Read full article (2 min)